Bulk RNA sequencing of skin biopsies from psoriasis patients treated with roflumilast or placebo
RNA-seq (gene expression) · human · 87 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 87 samples: 87 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in PsoriasisThe Journal of investigative dermatology · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE283313_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1193084 and SRA study SRP548780. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 87 sample titles: 87 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8659797 Pt 32 W0 NL Placebo
- GSM8659798 Pt 32 W0 L Placebo
- GSM8659799 Pt 32 W4 L Placebo
- GSM8659800 Pt 32 W12 L Placebo
- GSM8659801 Pt 33 W0 NL Placebo
- GSM8659802 Pt 33 W0 L Placebo
- GSM8659803 Pt 33 W4 L Placebo
- GSM8659804 Pt 33 W12 L Placebo
- GSM8659805 Pt 34 W0 NL Placebo
- GSM8659806 Pt 34 W0 L Placebo
- GSM8659807 Pt 34 W4 L Placebo
- GSM8659808 Pt 34 W12 L Placebo
- GSM8659809 Pt 35 W0 NL Roflumilast
- GSM8659810 Pt 35 W0 L Roflumilast
- GSM8659811 Pt 35 W4 L Roflumilast
- GSM8659812 Pt 35 W12 L Roflumilast
- GSM8659813 Pt 36 W0 NL Roflumilast
- GSM8659814 Pt 36 W0 L Roflumilast
- GSM8659815 Pt 36 W4 L Roflumilast
- GSM8659816 Pt 36 W12 L Roflumilast
- GSM8659817 Pt 37 W0 NL Roflumilast
- GSM8659818 Pt 37 W0 L Roflumilast
- GSM8659819 Pt 37 W4 L Roflumilast
- GSM8659820 Pt 37 W12 L Roflumilast
- GSM8659821 Pt 38 W0 NL Placebo
- GSM8659822 Pt 38 W0 L Placebo
- GSM8659823 Pt 38 W4 L Placebo
- GSM8659824 Pt 38 W12 L Placebo
- GSM8659825 Pt 39 W0 NL Roflumilast
- GSM8659826 Pt 39 W0 L Roflumilast
- GSM8659827 Pt 39 W4 L Roflumilast
- GSM8659828 Pt 39 W12 L Roflumilast
- GSM8659829 Pt 40 W0 NL Placebo
- GSM8659830 Pt 40 W0 L Placebo
- GSM8659831 Pt 40 W4 L Placebo
- GSM8659832 Pt 40 W12 L Placebo
- GSM8659833 Pt 46 W0 NL Placebo
- GSM8659834 Pt 46 W0 L Placebo
- GSM8659835 Pt 46 W4 L Placebo
- GSM8659836 Pt 46 W12 L Placebo
+ 47 more — browse all 87 samples with per-sample file links →
- GSE285522 Bulk RNA sequencing of skin biopsies from psoriasis patients treated with Dead Sea climatotherapy 30 samples shares psoriasis, biopsies, treated, bulk, skin
- GSE212476 Skin expression data from psoriasis patients treated with IL-17A inhibitor 40 samples shares psoriasis, treated, skin
- GSE311770 Minimally invasive 1 mm skin biopsies capture regional transcriptomic heterogeneity in vitiligo 105 samples shares biopsies, skin
- GSE290418 Bulk RNA-sequencing of human non-IBD enteroids treated with interferon-gamma (IFNγ) 12 samples shares treated, bulk
- GSE278330 Systemic IL-23 blockade downregulates IL-23 receptor-expressing Type 17 T-cell subsets and upregulates regulatory gene expression in myeloid cells in human psoriasis skin 63 samples shares psoriasis, skin
- GSE293037 Bulk transcriptome analysis of wildtype, TREM2 knockout, GPR34 knock-out or TREM2/GPR34 double knock-out iPSC-derived human microglia treated either with PBS or myelin. 32 samples shares treated, bulk
- GSE307519 bulk RNAseq of Ccd18-Co cell line treated with cytokine mix and/or epigenetic modulator 16 samples shares treated, bulk
- GSE272346 Late-stage tertiary lymphoid structures in hepatocellular carcinoma treated with neoadjuvant immune checkpoint blockade [bulk RNA-seq] 14 samples shares treated, bulk
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.